Suchergebnisse - (Subject:"Ritonavir")

PubPharm (9.301)

31

Paxlovid use is associated with lower risk of cardiovascular diseases in COVID-19 patients with autoimmune rheumatic diseases : a retrospective cohort study

enthalten in: BMC medicine | 2024

von Wang, W. | Wang, Y. | Huang, C. | +3

32

The Impacts of Nirmatrelvir-Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic

enthalten in: Cardiovascular drugs and therapy | 2024

von Gu, J. | Han, Z. | Wang, C. | +1

33

Translated article] Safety profile of nirmatrelvir-ritonavir : Evidence of adverse events due to DDIs

enthalten in: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria | 2024

von González-Gómez, �. | Caro-Teller, J. | González-Barrios, I. | +3

34

Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Loos, N. | Bui, V. | de Jong, D. | +4

35

Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19 : a systematic review and meta-analysis

enthalten in: Expert review of anti-infective therapy | 2024

von Amani, B. | Amani, B.

36

Nirmatrelvir and ritonavir

enthalten in: Clinical therapeutics | 2024

von Beninger, P.

37

The effects of nirmatrelvir/ritonavir on tacrolimus levels in lung transplant recipients : A single-center study

enthalten in: Pulmonary pharmacology & therapeutics | 2024

von Wang, X. | Du, W. | Zhang, D. | +2

38

Pharmacist's role in the management of drug-drug interactions caused by nirmatrelvir/ritonavir in COVID-19 oncohematology patients

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Guzmán Cordero, C. | Sáez-Torres de Vicente, M. | Jiménez Espinosa, �. | +1

39

Effectiveness and safety of nirmatrelvir-ritonavir in kidney transplant recipients with severe kidney dysfunction infected with COVID-19

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Yang, H. | Yu, X. | Hou, W. | +8

40

Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients

enthalten in: Cancers | 2024

von Haddad, A. | Hachem, R. | Moussa, M. | +5